MorphoSys – Pipeline
MorphoSys has numerous candidates in its clinical development pipeline. As of August 2009, its most advanced drug candidate is MOR103, a fully human HuCAL antibody directed against GM-CSF (granulocyte macrophage-colony stimulating factor), developed in the area of inflammatory diseases, i.
MorphoSys has numerous candidates in its clinical development pipeline.
As of August 2009, its most advanced drug candidate is MOR103, a fully human HuCAL antibody directed against GM-CSF (granulocyte macrophage-colony stimulating factor), developed in the area of inflammatory diseases, i.e. rheumatoid arthritis.
Adapted from the Wikipedia article MorphoSys, under the G. N. U. Free Documentation License. Please also see http://en.wikipedia.org/wiki
If you enjoyed this article, please consider sharing it!
Related Articles
Related Videos
Ellen Shmueli, living with rheumatoid arthritis for more than 10 years, shares her experience of being diagnosed and finding a rheumatologist who worked with her...
rheumatoidarthritissymptomstest.com - Rheumatoid Arthritis Symptoms, what can you learn about this condition....
Rheumatoid arthritis affects 1.3 million Americans. Research advances and drug development have helped control this chronic disease. Noted UCLA Rheumatology expert Dr. Michael Weisman, presents...